Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy

Simple item page
dc.contributor.authorBeadle, R.
dc.contributor.authorWilliams, L.
dc.contributor.authorKuehl, M.
dc.contributor.authorBowater, S.
dc.contributor.authorAbozguia, K.
dc.contributor.authorLeyva, F.
dc.contributor.authorYousef, Z.
dc.contributor.authorWagenmakers, A.
dc.contributor.authorThies, F.
dc.contributor.authorHorowitz, J.
dc.contributor.authorFrenneaux, M.
dc.date.issued2015
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityRoger M. Beadle, Lynne K. Williams, Michael Kuehl, Sarah Bowater, Khalid Abozguia, Francisco Leyva, Zaheer Yousef, Anton J.M. Wagenmakers, Frank Thies, John Horowitz, Michael P. Frenneaux
dc.identifier.citationJACC: Heart Failure, 2015; 3(3):202-211
dc.identifier.doi10.1016/j.jchf.2014.09.009
dc.identifier.issn2213-1779
dc.identifier.issn2213-1787
dc.identifier.orcidHorowitz, J. [0000-0001-6883-0703]
dc.identifier.urihttp://hdl.handle.net/2440/117143
dc.language.isoen
dc.publisherElsevier
dc.rights© 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.jchf.2014.09.009
dc.subjectHeart failure; magnetic resonance spectroscopy; myocardial metabolism; perhexiline
dc.titleImprovement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications